WallStSmart

DXC Technology Co (DXC)vsInfosys Ltd ADR (INFY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Infosys Ltd ADR generates 56% more annual revenue ($19.85B vs $12.68B). INFY leads profitability with a 16.2% profit margin vs 3.3%. DXC appears more attractively valued with a PEG of 0.49. DXC earns a higher WallStSmart Score of 67/100 (B-).

DXC

Strong Buy

67

out of 100

Grade: B-

Growth: 4.7Profit: 5.5Value: 10.0Quality: 6.5
Piotroski: 6/9Altman Z: 1.13

INFY

Hold

48

out of 100

Grade: D+

Growth: 4.0Profit: 9.0Value: 7.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DXCUndervalued (+87.2%)

Margin of Safety

+87.2%

Fair Value

$107.64

Current Price

$12.01

$95.63 discount

UndervaluedFair: $107.64Overvalued
INFYSignificantly Overvalued (-200.8%)

Margin of Safety

-200.8%

Fair Value

$5.24

Current Price

$13.17

$7.93 premium

UndervaluedFair: $5.24Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DXC4 strengths · Avg: 10.0/10
PEG RatioValuation
0.4910/10

Growing faster than its price suggests

P/E RatioValuation
5.2x10/10

Attractively priced relative to earnings

Price/BookValuation
0.6x10/10

Reasonable price relative to book value

EPS GrowthGrowth
96.8%10/10

Earnings expanding 96.8% YoY

INFY3 strengths · Avg: 9.0/10
Return on EquityProfitability
32.7%10/10

Every $100 of equity generates 33 in profit

Market CapQuality
$53.86B9/10

Large-cap with strong market position

P/E RatioValuation
17.0x8/10

Attractively priced relative to earnings

Areas to Watch

DXC4 concerns · Avg: 2.5/10
Profit MarginProfitability
3.3%3/10

3.3% margin — thin

Debt/EquityHealth
1.523/10

Elevated debt levels

Revenue GrowthGrowth
-100.0%2/10

Revenue declined 100.0%

Altman Z-ScoreHealth
1.132/10

Distress zone — elevated risk

INFY3 concerns · Avg: 3.3/10
PEG RatioValuation
2.224/10

Expensive relative to growth rate

Revenue GrowthGrowth
3.2%4/10

3.2% revenue growth

EPS GrowthGrowth
-5.3%2/10

Earnings declined 5.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : DXC

The strongest argument for DXC centers on PEG Ratio, P/E Ratio, Price/Book. PEG of 0.49 suggests the stock is reasonably priced for its growth.

Bull Case : INFY

The strongest argument for INFY centers on Return on Equity, Market Cap, P/E Ratio. Profitability is solid with margins at 16.2% and operating margin at 18.0%.

Bear Case : DXC

The primary concerns for DXC are Profit Margin, Debt/Equity, Revenue Growth. Debt-to-equity of 1.52 is elevated, increasing financial risk. Thin 3.3% margins leave little buffer for downturns.

Bear Case : INFY

The primary concerns for INFY are PEG Ratio, Revenue Growth, EPS Growth.

Key Dynamics to Monitor

DXC carries more volatility with a beta of 1.04 — expect wider price swings.

INFY is growing revenue faster at 3.2% — sustainability is the question.

INFY generates stronger free cash flow (924M), providing more financial flexibility.

Monitor INFORMATION TECHNOLOGY SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

DXC scores higher overall (67/100 vs 48/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

DXC Technology Co

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

DXC Technology is an American multinational corporation that provides business-to-business information technology services.

Visit Website →

Infosys Ltd ADR

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

Infosys Limited offers next generation digital consulting, technology, outsourcing and services in North America, Europe, India and internationally. The company is headquartered in Bengaluru, India.

Want to dig deeper into these stocks?